Electroporation for the Delivery of DNA-based Vaccines and Immunotherapeutics: Current Clinical Developments

This publication has 83 references indexed in Scilit:

• Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma
  Journal of Clinical Oncology, 2008
• Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine
  Vaccine, 2008
• A consensus–hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses
  Proceedings of the National Academy of Sciences, 2008
• Multifunctional T-Cell Characteristics Induced by a Polyvalent DNA Prime/Protein Boost Human Immunodeficiency Virus Type 1 Vaccine Regimen Given to Healthy Adults Are Dependent on the Route and Dose of Administration
  Journal of Virology, 2008
• Heterosubtypic Protection against Pathogenic Human and Avian Influenza Viruses via In Vivo Electroporation of Synthetic Consensus DNA Antigens
  PLOS ONE, 2008
• Recruitment of Antigen-Presenting Cells to the Site of Inoculation and Augmentation of Human Immunodeficiency Virus Type 1 DNA Vaccine Immunogenicity by In Vivo Electroporation
  Journal of Virology, 2008
• Clinical Phase 1 Testing of the Safety and Immunogenicity of an Epitope-Based DNA Vaccine in Human Immunodeficiency Virus Type 1-Infected Subjects Receiving Highly Active Antiretroviral Therapy
  Clinical and Vaccine Immunology, 2008
• Whole tumor antigen vaccination using dendritic cells: Comparison of RNA electroporation and pulsing with UV-irradiated tumor cells
  Journal of Translational Medicine, 2008
• The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
  The Journal of Experimental Medicine, 2008
• Controlled expression of transgenes introduced by in vivo electroporation
  Proceedings of the National Academy of Sciences, 2007